Hua Medicine
$0.3039
1
+$0.00+0% Wednesday 18:03
Statistics
Day High
0.4107
Day Low
0.4107
52W High
0.5
52W Low
0.3039
Volume
100
Avg. Volume
190
Mkt Cap
321.1M
P/E Ratio
2.13
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20AugExpected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.16
0.32
0.81
1.29
Expected EPS
N/A
Actual EPS
-0.0349895097511848
Financials
221.11%Profit Margin
Profitable69.73MRevenue
154.18MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Hua Medicine (Shanghai) Ltd. is a clinical-stage pharmaceutical firm specializing in treatments for diabetes, primarily targeting the Chinese market. Its flagship product is Dorzagliatin (also known as HMS5552), an oral medication currently being developed for managing Type 2 Diabetes (T2D). Additionally, the company is advancing Dorzagliatin through Phase I clinical trials when combined with Metformin, Sitagliptin, and Empagliflozin, also for T2D therapy. Dorzagliatin's potential extends to other applications, including combinations with Pioglitazone for NASH, with GLP-1 for Alzheimer's disease, and for the management of both late-stage Type 2 and Type 1 Diabetes. Furthermore, Hua Medicine is also progressing mGLUR5, an investigational treatment targeting levodopa-induced dyskinesia in Parkinson's disease. Established in 2011, the company's operations are headquartered in Beijing, China.
Show more...
CEO
Li Chen
Employees
328
Country
Cayman Islands
ISIN
KYG4644K1022
Listings
0 Comments
Share your thoughts
FAQ
What is Hua Medicine stock price today?▼
The current price of HUMDF is $0.30 USD — it has increased by +0% in the past 24 hours. Watch Hua Medicine stock price performance more closely on the chart.
What is Hua Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Hua Medicine stocks are traded under the ticker HUMDF.
What is Hua Medicine market cap?▼
Today Hua Medicine has the market capitalization of 321.1M
When is the next Hua Medicine earnings date?▼
Hua Medicine is going to release the next earnings report on April 01, 2027.
What were Hua Medicine earnings last quarter?▼
HUMDF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Hua Medicine revenue for the last year?▼
Hua Medicine revenue for the last year amounts to 69.73M USD.
What is Hua Medicine net income for the last year?▼
HUMDF net income for the last year is 154.18M USD.
How many employees does Hua Medicine have?▼
As of September 04, 2026, the company has 328 employees.
In which sector is Hua Medicine located?▼
Hua Medicine operates in the Health & Wellness sector.
When did Hua Medicine complete a stock split?▼
Hua Medicine has not had any recent stock splits.
Where is Hua Medicine headquartered?▼
Hua Medicine is headquartered in Shanghai, Cayman Islands.